We are live on ! Find out more
PSC

Piper Sandler & Co Portfolio holdings

AUM $135M
1-Year Est. Return 0.15%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+0.15%
3 Year Est. Return
-0.04%
5 Year Est. Return
-7.65%
10 Year Est. Return
–
AUM
$39.4M
AUM Growth
-$54.1M
Cap. Flow
-$41.6M
Cap. Flow %
-105.57%
Top 10 Hldgs %
95.65%
Holding
123
New
16
Increased
1
Reduced
3
Closed
94

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$714K
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$462K
3
BHC icon
Bausch Health
BHC
+$222K
4
THC icon
Tenet Healthcare
THC
+$194K
5
BLUE
bluebird bio
BLUE
+$174K

Top Sells

Rank Stock Value
1
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$1.71M
2
TZA icon
Direxion Daily Small Cap Bear 3x ETF
TZA
+$1.19M
3
OFIX icon
Orthofix Medical
OFIX
+$996K
4
ESRX
Express Scripts Holding Company
ESRX
+$648K
5
EW icon
Edwards Lifesciences
EW
+$640K

Sector Composition

Rank Sector Weight
1 Healthcare 17.09%
2 Consumer Discretionary 0.45%
3 Communication Services 0%
4 Consumer Staples 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OFIX icon
51
Orthofix Medical
OFIX
$496M
– –
-29,500
Closed -$996K
PDFS icon
52
PDF Solutions
PDFS
$1.87B
– –
-25,000
Closed -$250K
PXLW icon
53
Pixelworks
PXLW
$37.2M
– –
-4,167
Closed -$181K
SIMO icon
54
Silicon Motion
SIMO
$7.51B
– –
-7,500
Closed -$205K
SNN icon
55
Smith & Nephew
SNN
$13.7B
– –
-15,000
Closed -$525K
SPXU icon
56
ProShares UltraPro Short S&P 500
SPXU
$416M
– –
-106
Closed -$1.71M
SQNS
57
Sequans Communications SA
SQNS
$39.5M
– –
-250
Closed -$26K
TCOM icon
58
Trip.com Group
TCOM
$28.5B
– –
-10,000
Closed -$316K
TNDM icon
59
Tandem Diabetes Care
TNDM
$1.22B
– –
-3,700
Closed -$326K
TZA icon
60
Direxion Daily Small Cap Bear 3x ETF
TZA
$245M
– –
-56
Closed -$1.19M
VCYT icon
61
Veracyte
VCYT
$4.44B
– –
-10,000
Closed -$47K
VNDA icon
62
Vanda Pharmaceuticals
VNDA
$310M
– –
-30,000
Closed -$338K
WW
63
DELISTED
WW International
WW
– –
-25,000
Closed -$160K
CMRX
64
DELISTED
Chimerix, Inc.
CMRX
$0 ﹤0.01%
+22
New +$792
INFN
65
DELISTED
Infinera Corporation Common Stock
INFN
– –
-15,000
Closed -$293K
PGTI
66
DELISTED
PGT, Inc.
PGTI
– –
-15,000
Closed -$184K
SIEN
67
DELISTED
Sientra, Inc.
SIEN
– –
-100
Closed -$10K
CYTO
68
DELISTED
Altamira Therapeutics Ltd
CYTO
– –
0
– –
NUVA
69
DELISTED
NuVasive, Inc.
NUVA
– –
-8,500
Closed -$410K
IMBI
70
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
– –
-5,000
Closed -$131K
SPNE
71
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
– –
-15,000
Closed -$243K
ZEN
72
DELISTED
ZENDESK INC
ZEN
– –
-15,000
Closed -$296K
TWTR
73
DELISTED
Twitter, Inc.
TWTR
– –
-15,000
Closed -$404K
NTUS
74
DELISTED
Natus Medical Inc
NTUS
– –
-12,500
Closed -$493K
TVTY
75
DELISTED
Tivity Health, Inc. Common Stock
TVTY
– –
-10,000
Closed -$111K
1 2
3
4 5

Similar funds

UOP
University of Pittsburgh Pittsburgh, Pennsylvania $135M AUM 29.36% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
ICM
Isabella Capital Management London $135M AUM
EC
Enhancing Capital Harrisburg, Pennsylvania $135M AUM 25.85% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
SA
Seneschal Advisors Tacoma, Washington $135M AUM 13.18% 1-Year Est. Return
JAA
Joel Adams & Associates Asheville, North Carolina $135M AUM 10.83% 1-Year Est. Return

Piper Sandler & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Piper Sandler & Co held 123 positions worth $39.4M, down 58% from $93.5M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Piper Sandler & Co withdrew a net $41.6M in Q4 2015, closing 94 positions and reducing 3 holdings. Its most notable exit was ProShares UltraPro Short S&P 500, an estimated $1.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Piper Sandler & Co opened a new position in Teva Pharmaceuticals worth $759K.

  • Piper Sandler & Co's largest Q4 2015 buy was Teva Pharmaceuticals: 11,559 shares worth $759K.
  • Piper Sandler & Co's biggest Q4 2015 reduction was vTv Therapeutics, cutting an estimated $626K.
  • Piper Sandler & Co fully exited ProShares UltraPro Short S&P 500 in Q4 2015, selling an estimated $1.71M.
  • Piper Sandler & Co's ten largest holdings make up 96% of its $39.4M portfolio in Q4 2015.
  • Piper Sandler & Co opened 16 new positions and closed 94 in Q4 2015.
  • Piper Sandler & Co's portfolio value fell 58% quarter-over-quarter to $39.4M.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.